Literature DB >> 19156451

Whole-genome conditional two-locus analysis identifies novel candidate genes for late-onset Parkinson's disease.

A González-Pérez1, J Gayán, J Marín, J J Galán, M E Sáez, L M Real, C Antúnez, A Ruiz.   

Abstract

Whole-genome epistasis analysis may add a new layer of knowledge to whole-genome association studies, permitting the identification of new candidate genes which are completely transparent during conventional single-locus analysis. We present the first whole-genome conditional two-locus analysis in Parkinson's disease (PD). We scanned the entire genome and selected markers that interacted with a set of well-known loci previously associated to PD (SNCA, Parkin, LRRK2, UCHL1, DJ-1, PINK and MAPT). Our work describes several loci potentially related to PD risk which interact with SNCA, PARK1 and LRRK2 markers. We propose conditional whole-genome two-locus association analysis as a valuable method that might be helpful in re-analysing and re-interpreting data from whole-genome association studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19156451     DOI: 10.1007/s10048-009-0170-8

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  43 in total

Review 1.  Mathematical multi-locus approaches to localizing complex human trait genes.

Authors:  Josephine Hoh; Jurg Ott
Journal:  Nat Rev Genet       Date:  2003-09       Impact factor: 53.242

2.  Confidence interval estimation of interaction.

Authors:  D W Hosmer; S Lemeshow
Journal:  Epidemiology       Date:  1992-09       Impact factor: 4.822

3.  Pathway-based approaches for analysis of genomewide association studies.

Authors:  Kai Wang; Mingyao Li; Maja Bucan
Journal:  Am J Hum Genet       Date:  2007-12       Impact factor: 11.025

4.  Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study.

Authors:  Alexis Elbaz; Lorene M Nelson; Haydeh Payami; John P A Ioannidis; Brian K Fiske; Grazia Annesi; Andrea Carmine Belin; Stewart A Factor; Carlo Ferrarese; Georgios M Hadjigeorgiou; Donald S Higgins; Hideshi Kawakami; Rejko Krüger; Karen S Marder; Richard P Mayeux; George D Mellick; John G Nutt; Beate Ritz; Ali Samii; Caroline M Tanner; Christine Van Broeckhoven; Stephen K Van Den Eeden; Karin Wirdefeldt; Cyrus P Zabetian; Marie Dehem; Jennifer S Montimurro; Audrey Southwick; Richard M Myers; Thomas A Trikalinos
Journal:  Lancet Neurol       Date:  2006-11       Impact factor: 44.182

5.  Mutation screening and association analysis of the parkin gene in Parkinson's disease patients from South-West China.

Authors:  Rong Peng; Yinru Gou; Qiang Yuan; Tao Li; Helen Latsoudis; Guanggu Yuan; Deru Luo; Xiehe Liu; David A Collier
Journal:  Eur Neurol       Date:  2003       Impact factor: 1.710

6.  Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.

Authors:  George D Mellick; Demetrius M Maraganore; Peter A Silburn
Journal:  Neurosci Lett       Date:  2004-11-23       Impact factor: 3.046

7.  Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease.

Authors:  Lisa Skipper; Yi Li; Carine Bonnard; Ratnagopal Pavanni; Yuen Yih; Eva Chua; Wing-Kin Sung; Louis Tan; Meng-Cheong Wong; Eng-King Tan; Jianjun Liu
Journal:  Hum Mol Genet       Date:  2005-11-03       Impact factor: 6.150

8.  A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction.

Authors:  Kristine A Pattin; Bill C White; Nate Barney; Jiang Gui; Heather H Nelson; Karl T Kelsey; Angeline S Andrew; Margaret R Karagas; Jason H Moore
Journal:  Genet Epidemiol       Date:  2009-01       Impact factor: 2.135

9.  Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium.

Authors:  C Paisán-Ruíz; E W Evans; S Jain; G Xiromerisiou; J R Gibbs; J Eerola; V Gourbali; O Hellström; J Duckworth; A Papadimitriou; P J Tienari; G M Hadjigeorgiou; A B Singleton
Journal:  J Med Genet       Date:  2006-02       Impact factor: 6.318

10.  Gene-centric characteristics of genome-wide association studies.

Authors:  Changzheng Dong; Ziliang Qian; Peilin Jia; Ying Wang; Wei Huang; Yixue Li
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240

View more
  4 in total

1.  Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?

Authors:  Joanna M Biernacka; Sebastian M Armasu; Julie M Cunningham; J Eric Ahlskog; Sun Ju Chung; Demetrius M Maraganore
Journal:  Parkinsonism Relat Disord       Date:  2011-08-03       Impact factor: 4.891

Review 2.  Genetics of type 2 diabetes-pitfalls and possibilities.

Authors:  Rashmi B Prasad; Leif Groop
Journal:  Genes (Basel)       Date:  2015-03-12       Impact factor: 4.096

Review 3.  The regulation and deregulation of Wnt signaling by PARK genes in health and disease.

Authors:  Daniel C Berwick; Kirsten Harvey
Journal:  J Mol Cell Biol       Date:  2013-10-09       Impact factor: 6.216

4.  Identifying the genetic components underlying the pathophysiology of movement disorders.

Authors:  Mario Ezquerra; Yaroslau Compta; Maria J Marti
Journal:  Appl Clin Genet       Date:  2011-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.